PATENT CLAIM ANALYSIS

Application Number: 16167974
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["544", "298000"]

Abstract:
The present disclosure concerns at least one entity chosen from compounds of Formula (I) and pharmaceutically acceptable salts thereof: wherein the variable groups X, R 1 , R 2 , R 3  m, n and p are as defined herein. The present disclosure also relates to methods for the preparation of at least one such entity, and intermediates useful in the preparation thereof, to pharmaceutical compositions containing at least one such entity, to the use of at least one such entity in the preparation of medicaments, and to the use of at least one such entity in the treatment of conditions such as, for example, allergic diseases, autoimmune diseases, viral diseases, and cancer.

Claim (Index 55):
The compound according to  claim 51 , wherein n is 0, or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 2.04762
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14401366', '15152497', '15766560', '13587575', '15269363']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.805262120385197
- 35 USC 102 Novelty (BERT): 0.5734526071736218
- Combined Prediction Score: 0.7820811690640395
- Mean Citation Score: 357.771932
- Max Citation Score: 529.9143
- Similarity Product: 367.24319072536827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test